Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2006 5
2007 3
2009 1
2016 1
2019 3
2020 2
2021 1
2022 1
2023 4
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

19 results

Results by year

Filters applied: . Clear all
Page 1
How In Vitro Assays Contribute to Allergy Diagnosis.
Casset A, Khayath N, de Blay F. Casset A, et al. Among authors: khayath n. Curr Allergy Asthma Rep. 2016 Nov;16(11):82. doi: 10.1007/s11882-016-0659-9. Curr Allergy Asthma Rep. 2016. PMID: 27864812 Review.
Improvement in severe asthma patients receiving biologics and factors associated with persistent insufficient control: a real-life national study.
Guilleminault L, Camus C, Raherison-Semjen C, Capdepon A, Bourdin A, Bonniaud P, Fry S, Devouassoux G, Blanc FX, Pison C, Dupin C, Khayath N, Courdeau J, Valcke-Brossollet J, Nocent-Ejnaini C, Rolland F, Lamandi C, Proust A, Ozier A, Portel L, Gaspard W, Roux-Claude P, Beurnier A, Martinez S, Dot JM, Hennegrave F, Vignal G, Auvray E, Paleiron N, Just N, Miltgen J, Russier M, Olivier C, Taillé C, Didier A. Guilleminault L, et al. Among authors: khayath n. Ther Adv Respir Dis. 2023 Jan-Dec;17:17534666231202749. doi: 10.1177/17534666231202749. Ther Adv Respir Dis. 2023. PMID: 37966015 Free PMC article.
Improvement of exertional dyspneoa in patients with chronic obstructive pulmonary disease and severe allergic asthma responding to omalizumab.
Pereira S, Verhille J, Cailliau E, Bonniaud P, Devouassoux G, Fry S, Guilleminault L, Khayath N, Leroyer C, Chenivesse C, Bautin N. Pereira S, et al. Among authors: khayath n. Clin Exp Allergy. 2023 Dec;53(12):1298-1301. doi: 10.1111/cea.14392. Epub 2023 Sep 13. Clin Exp Allergy. 2023. PMID: 37705326 No abstract available.
SARS-CoV-2 Pneumonia in Hospitalized Asthmatic Patients Did Not Induce Severe Exacerbation.
Grandbastien M, Piotin A, Godet J, Abessolo-Amougou I, Ederlé C, Enache I, Fraisse P, Tu Hoang TC, Kassegne L, Labani A, Leyendecker P, Manien L, Marcot C, Pamart G, Renaud-Picard B, Riou M, Doyen V, Kessler R, Fafi-Kremer S, Metz-Favre C, Khayath N, de Blay F. Grandbastien M, et al. Among authors: khayath n. J Allergy Clin Immunol Pract. 2020 Sep;8(8):2600-2607. doi: 10.1016/j.jaip.2020.06.032. Epub 2020 Jun 27. J Allergy Clin Immunol Pract. 2020. PMID: 32603901 Free PMC article.
19 results